Gene Therapy Market Share, Analysis, and Growth by 2031
Gene Therapy Market: Strategic Insights
Gene Therapy Market
-
CAGR (2023 - 2031)14.3% -
Market Size 2023
US$ 5.11 Billion -
Market Size 2031
US$ 25.69 Billion
Market Dynamics
GROWTH DRIVERS
- Advances in genetic research
- Growing demand for personalized medicine
FUTURE TRENDS
- Expanding gene therapy research
- Increasing clinical trials for genetic disorders
OPPORTUNITIES
- Emerging research in genetic diseases and treatments
- Expanding gene therapy pipeline
Key Players
- Novartis AG
- Astellas Pharma Inc
- Bristol Myers Squibb Company
- Bluebird Bio Inc
- Sanofi
- F Hoffmann La Roche Ltd
- Daiichi Sankyo
- CSL Behring
- Biogen
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Vectors
- Non-Viral Vectors and Viral Vectors
Indication
- Neurological Diseases
- Cancer
- Duchenne Muscular Dystrophy
- Hepatological Diseases
- Other Indications
Delivery Mode
- In-Vivo and Ex-Vivo